Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Disulfiram radiosensitizes hypoxic human colorectal cancer through inhibition of PHGDH

Autor: Van De Gucht, M., Dufait, I., Jiang, H., Corbet, C., De Mey, S., Wang, H., Vandenplas, H., Law, K. L., Gevaert, T., Feron, O., De Ridder, M.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3848::7ef9631075c0949161618dcba46c5117
https://biblio.vub.ac.be/vubir/disulfiram-radiosensitizes-hypoxic-human-colorectal-cancer-through-inhibition-of-phgdh(3231c615-972c-4d98-b4f0-03697162df3a).html

MO-0141 Sulfasalazine radiosensitizes hypoxic colorectal cancer cells through the inhibition of xCT.

Autor: Kerkhove, L., Dufait, I., De Ridder, M., de Mey, S., Geirnaert, F., Law, K.L., Vandenplas, H., Gevaert, T.

Publikováno v: In Radiotherapy and Oncology May 2022 170 Supplement 1:S116-S116

PO-1928 Radiation cooperates with modulation of serine in human hypoxic colorectal cancer cells.

Autor: Van De Gucht, M., Dufait, I., Demesmaeker, E., jiang, H., Corbet, C., de Mey, S., Vandenplas, H., Law, K.L., Gevaert, T., Feron, O., De Ridder, M.

Publikováno v: In Radiotherapy and Oncology August 2021 161 Supplement 1:S1643-S1643

Transcutaneous Vagal Nerve Stimulation Alone or in Combination With Radiotherapy Stimulates Lung Tumor Infiltrating Lymphocytes But Fails to Suppress Tumor Growth.

Autor: Reijmen E; Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, Belgium., De Mey S; Department of Radiotherapy, Oncology Centre University Hospital Brussels (Universitair Ziekenhuis (UZ) Brussel), Brussels, Belgium., Van Damme H; Myeloid Cell Immunology Lab, Vlaams Instituut voor Biotechnologie (VIB) Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., De Ridder K; Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, Belgium., Gevaert T; Department of Radiotherapy, Oncology Centre University Hospital Brussels (Universitair Ziekenhuis (UZ) Brussel), Brussels, Belgium., De Blay E; Cell Differentiation Lab, Vrije Universiteit Brussel, Brussels, Belgium., Bouwens L; Cell Differentiation Lab, Vrije Universiteit Brussel, Brussels, Belgium., Collen C; Department of Radiotherapy, Oncology Centre University Hospital Brussels (Universitair Ziekenhuis (UZ) Brussel), Brussels, Belgium., Decoster L; Laboratory of Medical and Molecular Oncology (LMMO), Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis (UZ) Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium., De Couck M; Department of Public Health, Mental Health and Wellbeing Research Group, Faculty of Medicine and Pharmacy, Vrije Universiteit Brussel, Brussels, Belgium.; Faculty of Health Care, University College Odisee, Aalst, Belgium., Laoui D; Myeloid Cell Immunology Lab, Vlaams Instituut voor Biotechnologie (VIB) Center for Inflammation Research, Brussels, Belgium.; Lab of Cellular and Molecular Immunology, Vrije Universiteit Brussel, Brussels, Belgium., De Grève J; Laboratory of Medical and Molecular Oncology (LMMO), Department of Medical Oncology, Oncologisch Centrum, Universitair Ziekenhuis (UZ) Brussel, Vrije Universiteit Brussel (VUB), Brussels, Belgium., De Ridder M; Department of Radiotherapy, Oncology Centre University Hospital Brussels (Universitair Ziekenhuis (UZ) Brussel), Brussels, Belgium., Gidron Y; Faculty of Social Welfare and Health Sciences, University of Haifa, Haifa, Israel., Goyvaerts C; Laboratory for Molecular and Cellular Therapy, Department of Biomedical Sciences, Vrije Universiteit Brussel, Brussels, Belgium.

Publikováno v: Frontiers in immunology [Front Immunol] 2021 Dec 01; Vol. 12, pp. 772555. Date of Electronic Publication: 2021 Dec 01 (Print Publication: 2021).